Log in
Enquire now
Curevo

Curevo

Curevo is a clinical-stage biotechnology company developing next-generation, non-mRNA vaccines for infectious diseases.

OverviewStructured DataIssuesContributors

Contents

curevovaccine.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Pharmaceutical industry
Pharmaceutical industry
Biotechnology
Biotechnology
Health technology
Health technology
Location
‌
Bothell, Washington
B2X
B2B
B2B
CEO
‌
George Simeon
Founder
‌
George Simeon
Number of Employees (Ranges)
11 – 50
Email Address
Phone Number
Investors
Sanofi Ventures
Sanofi Ventures
‌
Medicxi
‌
HBM Healthcare Investments
‌
GC Biopharma
Adjuvant Capital
Adjuvant Capital
Janus Henderson Investors
Janus Henderson Investors
OrbiMed
OrbiMed
RA Capital Management
RA Capital Management
Total Funding Amount (USD)
110,000,000
Latest Funding Round Date
March 17, 2025
Latest Funding Type
Series B
Series B

Other attributes

Latest Funding Round Amount (USD)
110,000,000
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Curevo

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Pricing
  • Enterprise

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.